2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-16918A
    Heptamidine dimethanesulfonate
    		Inhibitor 99.82%
    Heptamidine dimethanesulfonate (SBi4211 dimethanesulfonate) is a potent Pentamidine-related inhibitor of the calcium-binding protein S100B (Kd=6.9 μM), selectively kills melanoma cells with S100B over those without S100B. Heptamidine is a useful tool for the investigation of Myotonic dystrophy (DM).
    Heptamidine dimethanesulfonate
  • HY-153366
    TNG-0746132
    		99.66%
    TNG-0746132 can be used for synthesis of the compound with anticancer activity.
    TNG-0746132
  • HY-150289
    GNE-235
    		98.45%
    GNE-235 is a compound selective for the second bromodomain of PBRM1, with a KD of 0.28 ± 0.02 μM. GNE-235 can be used for evaluation of the cellular function of PBRM1.
    GNE-235
  • HY-103317
    NAADP
    NAADP, a nucleotide, is a Ca2+-mobilizing second messenger. NAADP is essential for initiation of Ca2+ signaling.
    NAADP
  • HY-125961
    T3Inh-1
    		98.82%
    T3Inh-1 is a potent and selective inhibitor of ppGalNAc-T3 (IC50=7 μM). T3Inh-1 reduces FGF23 hormone levels in both tissue cells and mice, without causing any toxic side effects. T3Inh-1 also prevents breast cancer cells. The enzyme ppGalNAc-T3 is implicated in at least two medically important pathways: cancer metastasis and stabilization of FGF23 (regulates phosphate levels in the bloodstream).
    T3Inh-1
  • HY-W143216
    Azure C
    Azure C is the product of sequential enzymatic oxidation of Methylene blue (MB) or Azure B (AB). Azure C serves as the substrate of horseradish peroxidase (HRP).
    Azure C
  • HY-33009
    AS057278
    		Inhibitor 99.76%
    AS057278 is a potent, selective, orally active and blood-brain barrier (BBB) penetrant non-peptidic D-amino acid oxidase (DAAO) inhibitor with an IC50 value of 0.91 μM and EC50 of 2.2-3.95 μM. AS057278 can normalize phencyclidine (PCP)-induced prepulse inhibition in mice. AS057278 can be used for researching schizophrenia.
    AS057278
  • HY-139059
    ERD03
    		Inhibitor 99.39%
    ERD03 is a potent disruptor of the EXOSC3-RNA interaction, with a Kd of 17±7 μM . ERD03 induces PCH1B-like phenotype in zebrafish embryo and can be used for neurological disorder disease research.
    ERD03
  • HY-B0544
    Sodium Picosulfate
    		≥98.0%
    Sodium Picosulfate (Sodium Picosulphate) is a contact irritant laxative with oral activity. Sodium Picosulfate inhibits the absorption of water and electrolytes, increasing their production. Sodium Picosulfate can be used in colonoscopy applications.
    Sodium Picosulfate
  • HY-156775
    Antitumor agent-119
    		98.03%
    Antitumor agent-119 (compound 13K) is a 2-benzoxazolyl hydrazone derivative with anticancer activities. Antitumor agent-119 inhibits the cell growth of Butkitt, CCRF-CEM, HeLa, and HT-29 with IC50 values of 30 nM, 140 nM, 100 nM, and 40 nM, respectively.
    Antitumor agent-119
  • HY-16395
    PG-11047
    		≥98.0%
    PG-11047 (CGC-11047) is a polyamine analogue. PG-11047 can be used for the research of breast cancer.
    PG-11047
  • HY-126710
    OU749
    		Inhibitor 98.83%
    OU749 is a potent γ-glutamyl transpeptidase (GGT) inhibitor with a Ki value of 17.6 µM. OU749 shows cytotoxicity.
    OU749
  • HY-153383
    PDCD4-IN-1
    		99.65%
    PDCD4-IN-1(compound 20031600) is a PDCD4 inhibitor with a Kd value of 350 nM, which can promote the expression of BDNF in hippocampal neuron cell HT-22.
    PDCD4-IN-1
  • HY-132822
    Ivospemin
    		Inhibitor 99.71%
    Ivospemin (SBP-101) is an antineoplastic spermine analog. Ivospemin has shown efficacy in slowing pancreatic and ovarian tumor progression in vitro and in vivo. Ivospemin shows modest induction of polyamine catabolism, but stronger repression of ornithine decarboxylase activity. Ivospemin is promising for research of cancers.
    Ivospemin
  • HY-15385
    Imexon
    		99.79%
    Imexon (BM 06002) is an iminopyrrolidone aziridine with anti-cancer activity.
    Imexon
  • HY-103001
    HMN-154
    HMN-154 is a novel benzenesulfonamide anticancer compound; inhibits KB and colon38 cells with IC50 values of 0.0026 and 0.003 μg/mL, respectively.
    HMN-154
  • HY-135094
    Palmitoyl glutamic acid
    		≥98.0%
    Palmitoyl glutamic acid (N-Palmitoyl-L-glutamic acid) is an acyl amino acid with neuroprotective effects. Palmitoyl glutamic acid is used as cosmetic material.
    Palmitoyl glutamic acid
  • HY-100303
    FR194738 free base
    		Inhibitor 99.84%
    FR194738 free base is a squalene epoxidase inhibitor. FR194738 inhibits squalene epoxidase activity in HepG2 cell homogenates with an IC50 of 9.8 nM.
    FR194738 free base
  • HY-107831
    5-Acetylsalicylic acid
    		99.84%
    5-Acetylsalicylic acid has anti-inflammatory and is considered to be the active agent in inflammatory bowel disease (IBD). 5-Acetylsalicylic acid is the derivate of Acetylsalicylic acid (HY-14654).
    5-Acetylsalicylic acid
  • HY-112085
    N-Bis(2-hydroxypropyl)nitrosamine
    		≥98.0%
    N-Bis(2-hydroxypropyl)nitrosamine is a tumor model inducing agent and a metabolite of di-n-propylnitrosamine (DPN). N-Bis(2-hydroxypropyl)nitrosamine can be used to construct pancreatic cancer.
    N-Bis(2-hydroxypropyl)nitrosamine
Cat. No. Product Name / Synonyms Application Reactivity